CENTO, ALESSIA SOFIA
 Distribuzione geografica
Continente #
NA - Nord America 1.793
EU - Europa 1.085
AS - Asia 473
AF - Africa 11
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 3.377
Nazione #
US - Stati Uniti d'America 1.780
IT - Italia 319
CN - Cina 203
SE - Svezia 138
IE - Irlanda 123
SG - Singapore 120
DK - Danimarca 118
DE - Germania 91
UA - Ucraina 74
GB - Regno Unito 49
VN - Vietnam 43
FR - Francia 39
FI - Finlandia 34
JP - Giappone 32
BE - Belgio 24
ID - Indonesia 20
AT - Austria 18
PL - Polonia 17
ES - Italia 16
KR - Corea 15
CA - Canada 11
HK - Hong Kong 10
AU - Australia 8
EG - Egitto 6
IN - India 6
NL - Olanda 6
TW - Taiwan 6
CH - Svizzera 5
EU - Europa 3
IR - Iran 3
TH - Thailandia 3
BG - Bulgaria 2
BR - Brasile 2
KZ - Kazakistan 2
LT - Lituania 2
MO - Macao, regione amministrativa speciale della Cina 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
RO - Romania 2
SN - Senegal 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AM - Armenia 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
KH - Cambogia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SI - Slovenia 1
TR - Turchia 1
Totale 3.377
Città #
Ann Arbor 337
Chandler 261
Dublin 122
Torino 101
Singapore 96
Santa Clara 95
Ashburn 87
Beijing 69
Fairfield 63
Nyköping 62
Wilmington 61
Jacksonville 58
Frankfurt am Main 53
Houston 53
Turin 44
Dearborn 40
Dong Ket 35
Woodbridge 33
Seattle 32
Cambridge 31
Medford 29
Columbus 26
Fremont 23
Pisa 21
Princeton 21
Villeurbanne 21
Jakarta 20
Brussels 19
Vienna 18
Guangzhou 16
Lappeenranta 16
Redwood City 16
Warsaw 16
London 13
Boston 12
Helsinki 11
San Diego 10
San Mateo 9
Boardman 8
Chengdu 8
Chions 7
New York 7
Los Angeles 6
Mornago 6
Tokyo 6
Toronto 6
Umeda 6
Vigo 6
Wuhan 6
Zhengzhou 6
Aosta 5
Hangzhou 5
Hong Kong 5
Nanjing 5
San Mauro Torinese 5
Seoul 5
Taipei 5
Zurich 5
Hanover 4
Ilkley 4
Munich 4
Nakasuji 4
Shanghai 4
Stockholm 4
Upper Marlboro 4
Washington 4
Xian 4
Berkeley 3
Bra 3
Gava 3
Guiyang 3
Hebei 3
Milan 3
Nagoya 3
Nanchang 3
Nuremberg 3
Ottawa 3
Palermo 3
Riverton 3
Rochester 3
Samarate 3
San Francisco 3
Shenzhen 3
Torre del Greco 3
Albizzate 2
Alessandria 2
Almaty 2
Amersfoort 2
Atlanta 2
Bonn 2
Borgaro Torinese 2
Buffalo 2
Castiglione 2
Catania 2
Central District 2
Clifton 2
Cobleskill 2
Durham 2
Fort Worth 2
Gangbuk-gu 2
Totale 2.287
Nome #
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study 330
SALIVAGE – EU JPI Project The “form” makes the difference: comprehensive two‐dimensional gas chromatography as highly informative fingerprinting tool to study the impact of fructose formulation on mice’s microbiota and its volatile metabolome signatures 231
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 205
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts 191
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 187
Pyridoxamine prevents diet-induced insulin resistance through the regulation of ceramide/sphingosine/sphingosine-1-phosphate equilibrium in mice liver 186
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons 178
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation 153
Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes 150
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 132
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction 129
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 129
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice 128
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction 119
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation 113
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades 105
AGEs induce alterations of sphingolipids metabolism in the liver of genetically- and diet-induced diabetic mice 101
Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose 96
Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems 94
Baricitinib counteracts metaflammation protecting against diet-induced metabolic abnormalities in mice 92
KRIT1/CCM1 Loss-of-function Mutations Impair Anti-glycative and Anti-oxidant Systems Worsening High Fructose Diet-induced Hepatic Dismetabolism 88
KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance 71
KRIT1/CCM1 loss-of-function impairs advanced glycation endproducts receptors and detoxification and worsens fructose diet-induced hepatic dysmetabolism 71
Inhibition of AGEs by pyridoxamine prevents diet-induced systemic inflammation and skeletal muscle insulin resistance by restoring SphK/S1P3/RhoA signalling 65
Genetic deletion of RAGE in db/db mice interferes in the liver with other AGE-receptors and AGE-detoxifying systems sustaining lipogenesis and inflammation 65
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress 37
Exercise and Exercise Mimetics for the Treatment of Musculoskeletal Disorders 20
The BET inhibitor JQ1 targets fat metabolism and counteracts obesity 19
The role of advanced glycation end products and inflammation in the development of chronic diseases 5
Totale 3.490
Categoria #
all - tutte 11.396
article - articoli 0
book - libri 0
conference - conferenze 3.794
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020294 0 0 0 0 0 47 46 38 49 30 44 40
2020/2021514 20 42 30 43 54 47 35 26 50 37 24 106
2021/2022739 57 46 59 58 65 46 55 58 33 50 117 95
2022/2023797 59 85 26 90 61 182 55 56 103 25 36 19
2023/2024349 40 54 21 20 23 31 13 32 11 35 36 33
2024/2025382 15 22 39 64 169 73 0 0 0 0 0 0
Totale 3.490